Branded Generics Market: By Disease Indication (Cardiovascular Diseases, Diabetes, Cancer, Neurological Disorders, Gastrointestinal Diseases, Dermatology Diseases, and Others), By Route of Administration (Oral, Parenteral, Topical, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Branded Generics market size is valued at USD 242.4 billion in 2022 and is poised to grow at a CAGR of 5.9% from 2023 to 2029. The global market provides a detailed overview of the Branded Generics market and which can be segmented by disease, route of administration, distribution channel, and region. By disease, the Branded Generics market has been segmented into cardiovascular diseases, diabetes, cancer, neurological disorders, gastrointestinal diseases, dermatology diseases, and others. By disease, the cardiovascular disease segment accounts for increasing sales of branded generics in the global market. According to World Health Organization (WHO), around 17.9 million people die every year from cardiovascular diseases (CVDs) across the world. Correspondingly, 1.13 billion people worldwide have hypertension. This leads to the adoption of branded generics such as anti-hypertensive drugs, which ultimately expands branded generics market.  By route of administration, the Branded Generics market has been segmented into oral, parenteral, topical, and others. By route of administration, the oral segment leads the branded generics market with a significant share. The segments growth can be attributed to the convenience factor associated with oral administration. Oral medications are easy to administer and patient compliance with oral medication is more than other routes of administration. Furthermore, tablets and capsules are being made more palatable using sweeteners and colored coatings. Based on the distribution channel, the segment has been segregated into hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. Online Pharmacies are expected to have a considerable growth rate owing to the emergence of e-commerce, and manufacturers are forging alliances with online and retail pharmacies. An unprecedented pandemic of COVID-19 regularised branded generics shopping via online pharmacies. Patients find it easy and timesaving to get their medication from online pharmacies directly. As a result, online pharmacies are projected to gain traction through 2022 and beyond. By region, the North America market is expected to witness the highest market share during the forecast period owing to the well-established healthcare facilities and increasing prevalence of chronic diseases across the region, such as cardiovascular diseases, diabetes, Alzheimer's diseases, and Parkinson's diseases boosting the demand of branded generics market.

Branded Generics Market Key Developments:

  • In May 2021, Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced the launch of THIOLA (tiopronin) tablets for the presentation of cystine (kidney) stones.
  • In July 2021, Lupin announced that it will acquire Australia-based Southern Cross Pharma Pvt Ltd (SCP).

Global Branded Generics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.9%

Largest Market

Europe

Fastest Growing Market

Asia Pacific
Branded Generics Market Dynamics

Global market is primarily driven by a significant increase in cardiometabolic risk factors among a large proportion of people. The increasing prevalence of cancer cases is also playing an important role in the growth of the Branded Generics Market. However, a major factor, which is anticipated to hamper the growth of the market during the forecast period, is the misapplication of risk evaluation and mitigation strategies (REMS) to branded generics market entry.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Branded Generics Market Segmentation

By Indication
  • Cardiovascular
  • Diabetes
  • Cancer
  • Neurological Disorders
  • Gastrointestinal Diseases
  • Dermatology Diseases
  • Others
By Route Administration
  • Oral
  • Parenteral
  • Topical
  • Others
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

Frequently Asked Questions

The increasing prevalence of cancer cases is playing a major role in the growth of the branded generics market. Also, many pharmaceutical products become off-patent throughout the forecast period, and the worldwide branded generics market is expected to increase rapidly. Simple marketing approval procedures, new player participation, changing medication procedures, and higher profit margins are all anticipated to boost the global branded generics industry

The introduction of new branded generics, encouraging the usage of branded generics by healthcare suppliers and professionals, and a two-tiered strategy are major key trends pushing the market.

The U.S., China, India, Russia, and Brazil are the key manufacturers of branded generics.

The cardiovascular segment is expected to account for the largest share of the branded generics market during the forecast period, due to the increasing prevalence of the diseases among a large mass.

1. Executive Summary
2. Global Branded Generics Market Introduction 
2.1.Global Branded Generics Market  - Taxonomy
2.2.Global Branded Generics Market  - Definitions
2.2.1.Indication
2.2.2.Route of Administration
2.2.3.Distribution Channel
2.2.4.Region
3. Global Branded Generics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Branded Generics Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Branded Generics Market  By Indication, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Cardiovascular
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Diabetes
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Cancer
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Neurological Disorders
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Gastrointestinal Diseases
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Dermatology Diseases
5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Others
5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
6. Global Branded Generics Market  By Route of Administration, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Oral
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Parenteral
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Topical
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7. Global Branded Generics Market  By Distribution Channel, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Hospital Pharmacies
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Retail Pharmacies
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Drug Stores
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Online Pharmacies
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8. Global Branded Generics Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Branded Generics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Cardiovascular
9.1.2.Diabetes
9.1.3.Cancer
9.1.4.Neurological Disorders
9.1.5.Gastrointestinal Diseases
9.1.6.Dermatology Diseases
9.1.7.Others
9.2.  Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Oral
9.2.2.Parenteral
9.2.3.Topical
9.2.4.Others
9.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospital Pharmacies
9.3.2.Retail Pharmacies
9.3.3.Drug Stores
9.3.4.Online Pharmacies
9.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Branded Generics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Indication Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Cardiovascular
10.1.2.Diabetes
10.1.3.Cancer
10.1.4.Neurological Disorders
10.1.5.Gastrointestinal Diseases
10.1.6.Dermatology Diseases
10.1.7.Others
10.2.  Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Oral
10.2.2.Parenteral
10.2.3.Topical
10.2.4.Others
10.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital Pharmacies
10.3.2.Retail Pharmacies
10.3.3.Drug Stores
10.3.4.Online Pharmacies
10.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
10.4.7.
11. Asia Pacific (APAC) Branded Generics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Indication Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Cardiovascular
11.1.2.Diabetes
11.1.3.Cancer
11.1.4.Neurological Disorders
11.1.5.Gastrointestinal Diseases
11.1.6.Dermatology Diseases
11.1.7.Others
11.2.  Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Oral
11.2.2.Parenteral
11.2.3.Topical
11.2.4.Others
11.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital Pharmacies
11.3.2.Retail Pharmacies
11.3.3.Drug Stores
11.3.4.Online Pharmacies
11.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Branded Generics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Indication Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Cardiovascular
12.1.2.Diabetes
12.1.3.Cancer
12.1.4.Neurological Disorders
12.1.5.Gastrointestinal Diseases
12.1.6.Dermatology Diseases
12.1.7.Others
12.2.  Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Oral
12.2.2.Parenteral
12.2.3.Topical
12.2.4.Others
12.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital Pharmacies
12.3.2.Retail Pharmacies
12.3.3.Drug Stores
12.3.4.Online Pharmacies
12.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Branded Generics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Indication Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Cardiovascular
13.1.2.Diabetes
13.1.3.Cancer
13.1.4.Neurological Disorders
13.1.5.Gastrointestinal Diseases
13.1.6.Dermatology Diseases
13.1.7.Others
13.2.  Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Oral
13.2.2.Parenteral
13.2.3.Topical
13.2.4.Others
13.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital Pharmacies
13.3.2.Retail Pharmacies
13.3.3.Drug Stores
13.3.4.Online Pharmacies
13.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Abbott Laboratories (U.S.)
14.2.2.Apotex Inc. (Canada)
14.2.3.AstraZeneca (U.K)
14.2.4.Reddys Laboratories Ltd. (India)
14.2.5.GlaxoSmithKline plc (U.K)
14.2.6.Mylan N.V. (U.S.)
14.2.7.Pfizer Inc. (U.S)
14.2.8.Novartis AG (Switzerland)
15. Research Methodology 
16. Appendix and Abbreviations 
  • Abbott Laboratories (U.S.)
  • Apotex Inc. (Canada)
  • AstraZeneca (U.K)
  • Reddys Laboratories Ltd. (India)
  • GlaxoSmithKline plc (U.K)
  • Mylan N.V. (U.S.)
  • Pfizer Inc. (U.S)
  • Novartis AG (Switzerland)
  • Sanofi (France)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Valeant Pharmaceuticals International, Inc. (Canada)

Adjacent Markets